Camber Pharmaceuticals Inc
Jenna Maffucci has extensive experience in customer service and returns analysis. Currently serving as a Returns Analyst at Camber Pharmaceuticals Inc since January 2016, Jenna previously held various roles, including Cashier, Customer Service Representative, and File Maintenance Clerk at Stop & Shop, where employment began in 2008. Jenna holds a Master of Business Administration degree in Business Administration and Management from Wagner College, earned between 2013 and 2014, as well as a Bachelor's Degree in Sociology from Wagner College, completed in 2013.
Camber Pharmaceuticals Inc
Camber is made up of three groups with one common goal: to be the best generics company in the industry. Camber Pharmaceuticals is rapidly growing and had an industry-leading 28 product approvals in 2022. With the support of our parent company, Hetero, we are poised to have a record number of product approvals and launches in 2023. Hetero, a world leader in API production and vertical manufacturing, is the foundation upon which Camber has maintained a 99% service level for our customers for the past two years. Hetero is investing over $250 million in the next three years in Camber products. The research and development team consists of over 1,000 scientists working to expand the types of drugs Camber offers, including novel delivery systems and complex molecules.